Technology Office Says Prostate Cancer Screening Not Proven to Save Lives

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 8
Volume 4
Issue 8

WASHINGTON--A report released by the Congressional Office of Technology Assessment (OTA) says that screening for prostate cancer has not yet been proven to save lives. The report concluded: "Because scientific knowledge is limited, but the consequences of prostate cancer and its treatment are serious, an informed and reasonable patient could equally well decide to have screening or forego it." Nevertheless, OTA said that it would be reasonable for Medicare to consider reimbursement for such screening.

WASHINGTON--A report released by the Congressional Office of TechnologyAssessment (OTA) says that screening for prostate cancer has notyet been proven to save lives. The report concluded: "Becausescientific knowledge is limited, but the consequences of prostatecancer and its treatment are serious, an informed and reasonablepatient could equally well decide to have screening or foregoit." Nevertheless, OTA said that it would be reasonable forMedicare to consider reimbursement for such screening.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Ongoing studies in kidney cancer aim to explore determinants of immune-related adverse effects and strategies for mitigating them.
Machine learning-based approaches may play a role in further understanding of how somatic alterations influence responses or resistance to therapy.
Data from a first-in-disease trial assessing a personalized cancer vaccine in RCC require validation at a larger level, according to David Braun, MD, PhD.